A new role of the HIV-1 nucleocapsid in the spatiotemporal control of the reverse transcription throughout the virus replication cycle
© Yu et al; licensee BioMed Central Ltd. 2009
Published: 24 September 2009
Retroviral nucleocapsid (NC) is multifunctional in that it acts throughout the virus replication cycle via a number of molecular interactions. During the early stage, mature NC molecules extensively interact with the viral genome and reverse transcriptase to chaperone proviral DNA synthesis. At the late stage, NC as part of Gag, selects and dimerizes the genomic RNA, which is thought to start the Gag assembly process in infected cells. Interestingly, the RT reaction appears to be tightly controlled during the late steps of HIV-1 replication since the viral DNA synthesis is completed only after virions infect target cells . How this is regulated is yet poorly understood and we hypothesized that the NC might be involved in the timing of RT. To function, NC needs its two conserved CCHC zinc fingers and the flanking basic residues. Therefore, we investigated their role in the temporal control of the RT.
We undertook a detailed quantitative analysis of the viral nucleic acid production throughout the replication cycle by qPCR and qRT-PCR. We measured the effects of NC zinc finger and basic residue deletions and mutations on the conversion of both the genomic and spliced RNA species into DNA. We discovered that viral particles released from the cells expressing HIV-1 NC mutants, contained a high level of DNA (up to 100-fold as compared with wild-type HIV-1) [2, 3]. This unexpected accumulation of DNA in NC mutant virions was also independently reported by Thomas et al . Furthermore, we reported for the first time that intravirion DNA presence did not result from natural endogenous reverse transcriptase activity (NERT), but rather from the activation of the RT in the virus producer cells [2, 3].
These results provide the first example of RT during the late steps of HIV-1 replication and could bring an alternative explanation for the presence of viral DNA in HIV-1 particles isolated from the peripheral blood and semen of HIV-1-infected patients . The occurrence of late RT inside producer cells is also a property of the foamy viruses that release viral DNA-containing particles and whose Gag domain naturally lacks NC zinc-fingers. It is of great interest to determine whether such timing RT control is a characteristic of the HIV-1 NC or rather a common characteristic among all retroviruses. These investigations are in progress.
Last, these new findings on the role of HIV-1 NC emphasize the fact that the conserved zinc-finger motifs should be viewed as a major target for new drugs against HIV-1.
This work was supported by grants from ANRS, SIDACTION and CNRS. YB was supported by RTRS, LH by SIDACTION , and LD by ANRS. We thank Emilie Dumas for support of our current investigation.
- Mougel M, Houzet L, Darlix JL: When is it time for reverse transcription to start and go?. Retrovirology. 2009, 6:Google Scholar
- Houzet L, Morichaud Z, Didierlaurent L, Muriaux D, Darlix JL, Mougel M: Nucleocapsid mutations turn HIV-1 into a DNA-containing virus. Nucleic Acids Res. 2008, 36: 2311-9. 10.1093/nar/gkn069.PubMed CentralView ArticlePubMedGoogle Scholar
- Didierlaurent L, Houzet L, Morichaud Z, Darlix JL, Mougel M: The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation. Nucleic Acids Res. 2008, 36: 4745-53. 10.1093/nar/gkn474.PubMed CentralView ArticlePubMedGoogle Scholar
- Thomas JA, Bosche WJ, Shatzer TL, Johnson DG, Gorelick RJ: Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription. J Virol. 2008, 82: 9318-28. 10.1128/JVI.00583-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang H, Dornadula G, Pomerantz RJ: Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells. J Virol. 1996, 70: 2809-2824.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd.